Omada Health CEO sells 14,960 shares in plan

Omada Health CEO Sean P. Duffy disclosed Rule 10b5-1 plan-based sales totaling 14,960 shares and significant indirect trust holdings.

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) reported that Chief Executive Officer and director Sean P. Duffy sold a total of 14,960 shares of common stock on September 10, 2026 in open-market transactions made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. The filing also reports 851,659 shares of common stock held indirectly in family trusts for the benefit of his family members, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary 10b5-1

Net Seller: 14,960 shares

Net Sell 3 txns

Insider Duffy Sean P.

Role Chief Executive Officer

Sold 14,960 shs ($327K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	13,560	$21.7971	$296K
Sale	Common Stock F1, F3	1,400	$22.5916	$32K
holding	Common Stock F4	--	--	--

Holdings After Transaction: Common Stock — 382,594 shares (Direct); Common Stock — 851,659 shares (Indirect, See footnote)

Footnotes (4)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $21.38 to $22.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. F3. This transaction was executed in multiple trades at prices ranging from $22.41 to $22.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. F4. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

Key Figures

Shares sold (first transaction): 13,560 shares Price per share (first transaction weighted average): $21.7971 per share Shares sold (second transaction): 1,400 shares +3 more

6 metrics

Shares sold (first transaction) 13,560 shares Common stock sale on September 10, 2026 at weighted average price

Price per share (first transaction weighted average) $21.7971 per share Executed in multiple trades ranging from $21.38 to $22.325

Shares sold (second transaction) 1,400 shares Common stock sale on September 10, 2026 at weighted average price

Price per share (second transaction weighted average) $22.5916 per share Executed in multiple trades ranging from $22.41 to $22.77

Total shares sold 14,960 shares Net shares sold in reported transactions on September 10, 2026

Indirectly held shares in family trusts 851,659 shares Common stock held indirectly in family trusts, with beneficial ownership disclaimed except for pecuniary interest

Key Terms

Rule 10b5-1 trading plan, weighted average price, pecuniary interest, indirect

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported above reflects the weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

pecuniary interest financial

"disclaims beneficial ownership ... except to the extent of his pecuniary interest"

indirect financial

"Held in family trusts for the benefit of the Reporting Person's family members"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OMDA report for CEO Sean P. Duffy on September 10, 2026?

Omada Health (OMDA) reported that CEO Sean P. Duffy sold 14,960 shares of common stock on September 10, 2026 in open-market transactions, under a Rule 10b5-1 trading plan adopted on March 13, 2026.

At what prices were Sean P. Duffy’s OMDA shares sold on September 10, 2026?

Sean P. Duffy sold 13,560 shares at a weighted average price of $21.7971 per share, with trade prices ranging from $21.38 to $22.325, and 1,400 shares at a weighted average price of $22.5916, with trade prices ranging from $22.41 to $22.77.

How many OMDA shares did Sean P. Duffy sell in total in this Form 4?

The Form 4 reports total sales of 14,960 shares of Omada Health (OMDA) common stock on September 10, 2026, combining 13,560 shares in one transaction and 1,400 shares in another.

Were Sean P. Duffy’s OMDA stock sales made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Sean P. Duffy on March 13, 2026, and the Rule 10b5-1 checkbox for the filing is affirmed.

What indirect OMDA share holdings related to Sean P. Duffy are reported?

The Form 4 reports 851,659 shares of Omada Health common stock held indirectly in family trusts for the benefit of Sean P. Duffy’s family members. He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 05:14 PM Accepted by SEC EDGAR 09/14/2026 - 05:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffy Sean P.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2026		S(1)		13,560	D	$21.7971(2)	383,994	D
Common Stock	09/10/2026		S(1)		1,400	D	$22.5916(3)	382,594	D
Common Stock								851,659	I	See footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This transaction was executed in multiple trades at prices ranging from $21.38 to $22.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $22.41 to $22.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

	/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)